Clinical Trial Update: Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on Blue Cap showing efficacy and safety for treating atopic dermatitis in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Blue Cap

Snippet

Sponsor: Catalysis SL | Conditions: Atopic Dermatitis, Atopic Dermatitis and Related Conditions | Phase 3 | Status: COMPLETED